To read the full story, subscribe or sign in.

AstraZeneca supports Canadian National Access Project for Cancer Testing

Feb. 10, 2015

BioWorld Science Collaboration Cancer

Today's news in brief

BioWorld

BioWorld briefs for April 27, 2026.

Detecting the invisible: minimal residual disease at AACR 2026

BioWorld Science

Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....

A free gene therapy? Regeneron’s Otarmeni approved for hearing loss

BioWorld

Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...

News in brief

BioWorld Asia

BioWorld Asia briefs for April 28, 2026

Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists

BioWorld Science

Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...